The Changing Use of Pneumococcal Vaccine in Developed Countries

The Changing Use of Pneumococcal Vaccine in Developed Countries

Saved in:

Bibliographic Details
Main Author:	David S Fedson
Format:	Article
Language:	English
Published:	Wiley 1999-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1999/387043
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disparities in Effectiveness of Pneumococcal Vaccine in Industrialized and Developing Countries: Is Vaccination Closing the Gap?
by: R. Kornetsky, et al.
Published: (2020-05-01)

INCIDENCE OF PNEUMOCOCCAL INFECTION IN THE WESTERN EUROPEAN COUNTRIES. INTERNATIONAL EXPERIENCE IN USING SEVEN-VALENT PNEUMOCOCCAL CONJUGATED VACCINE
by: article editorial
Published: (2008-03-01)

What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal vaccines in developing countries?
by: J Anthony G Scott, et al.
Published: (2008-04-01)

Approaches to vaccination of adults against pneumococcal disease in different countries of the world
by: A. S. Korovkin, et al.
Published: (2024-07-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013-01-01)

Pneumococcal vaccines in China
by: Shanshan Wang, et al.
Published: (2025-12-01)

Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection
by: M. V. Savkina, et al.
Published: (2021-12-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
by: Carina Valente, et al.
Published: (2012-01-01)

Pneumococcal Vaccine for Infants and Toddlers
by: T. Mitchell
Published: (2006-08-01)

State of pneumococcal vaccine immunity
by: Mustafa Akkoyunlu
Published: (2024-12-01)

Pneumococcal Polysaccharide Conjugated Vaccines and the Problem of Changing Circulating Serotypes of Pneumococcus
by: N. N. Kostyukova, et al.
Published: (2023-11-01)

Approaches to assess new pneumococcal vaccines for immunogenicity, development and licensure
by: Feroze A. Ganaie, et al.
Published: (2025-12-01)

Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development
by: Kristen Feemster, et al.
Published: (2024-08-01)

The Burden of Pneumococcal Disease in the Canadian Population Before Routine Use of the Seven-Valent Pneumococcal Conjugate Vaccine
by: Adrienne Morrow, et al.
Published: (2007-01-01)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
by: Francesca Fortunato, et al.
Published: (2015-01-01)

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: David G. McIntosh
Published: (2009-04-01)

Pneumococcal Vaccine in Patients with Recurrent Infections
by: Mariana de Gouveia-Pereira Pimentel, et al.
Published: (2025-06-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

Indirect effect and pneumococcal conjugate vaccines
by: L. Temimi
Published: (2009-10-01)

Anti-pneumococcal vaccination in Cuba. Challenges
by: Dunia María Chávez Amaro, et al.
Published: (2019-02-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Pneumococcal vaccination in the focus of public attention
by: article Editorial
Published: (2021-12-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTION IN CANADA
by: Caroline Quach
Published: (2014-01-01)

Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine.
by: Martin O C Ota, et al.
Published: (2012-01-01)

A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics
by: Aurelija Petrutienė, et al.
Published: (2025-08-01)

Introduction of the pneumococcal conjugate vaccine in humanitarian and fragile contexts: Perspectives from stakeholders in four African countries
by: Baldeep K. Dhaliwal, et al.
Published: (2024-12-01)

Pneumococcal vaccination in older adults: A useful, but underused weapon
by: Filipić Brankica
Published: (2025-01-01)

Evaluation of efficacy and effectiveness across the pneumococcal conjugate vaccine era
by: David C. LaFon
Published: (2025-12-01)

Adolescent pneumococcal pneumonia with pleural effusion in developing country: a case report
by: Siti Annisa Dewi Rani, et al.
Published: (2025-06-01)

Review of Pneumococcal Vaccination Programs across Canada
by: SL Deeks, et al.
Published: (1999-01-01)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.
by: Sweta M Patel, et al.
Published: (2022-01-01)

Burden of pneumococcal disease in children in Cuba before the introduction of a novel pneumococcal conjugate vaccine
by: Nivaldo Linares-Pérez, et al.
Published: (2019-10-01)

Pneumococcal vaccination for children and adults: advances and achievements
by: article Editorial
Published: (2022-05-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

The full benefits of adult pneumococcal vaccination: A systematic review.
by: Elizabeth T Cafiero-Fonseca, et al.
Published: (2017-01-01)

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis
by: M. S. Naumtseva, et al.
Published: (2015-08-01)

Seasonality of Pneumococcal Nasopharyngeal Carriage in Rural Gambia Determined within the Context of a Cluster Randomized Pneumococcal Vaccine Trial.
by: Abdoulie Bojang, et al.
Published: (2015-01-01)

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024
by: King-Pui Florence Chan, et al.
Published: (2025-05-01)

Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)
by: Tao Chen, et al.
Published: (2022-07-01)